SERPINB5 and neoplasm: Taken together, these data not only demonstrated maspin-mediated repression of AR expression to augment epi-drug’s anti-tumor activity but also provided in-depth support for combination treatment strategy with AR antagonist and HDAC inhibitors in CaP therapy.